SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-009249
Filing Date
2021-04-20
Accepted
2021-04-20 16:05:47
Documents
21
Period of Report
2021-04-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50696
2 ex1-1.htm EX-1.1 226516
3 ex4-1.htm EX-4.1 627610
4 ex4-2.htm EX-4.2 172974
5 ex5-1.htm EX-5.1 11713
6 ex99-1.htm EX-99.1 15694
7 ex99-2.htm EX-99.2 15575
8 image_011.jpg GRAPHIC 6483
9 image_003.jpg GRAPHIC 9155
10 image_002.jpg GRAPHIC 9045
  Complete submission text file 0001493152-21-009249.txt   1519034

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE hrow-20210420.xsd EX-101.SCH 3026
12 XBRL LABEL FILE hrow-20210420_lab.xml EX-101.LAB 34914
13 XBRL PRESENTATION FILE hrow-20210420_pre.xml EX-101.PRE 22789
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3770
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 21837895
SIC: 2834 Pharmaceutical Preparations